Back to Stocks
Rank #1831BDSX
Biodesix, Inc.
$12.75
1.93% (Daily)
Market Cap
$102.00M
Revenue
$80.17M
Rank by MCap
#1831
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Scott Hutton
Headquarters
Louisville, CO
Employees
273
About Biodesix, Inc.
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strate...
Biodesix, Inc. Price Chart
Loading chart…